Tuesday, September 25, 2018
 
 
Company News: Page (1) of 1 - 05/21/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Regenerative Medicine Market Analysis Study Found Huge Boom By Rising Prevalence Of Chronic Diseases And Genetic Disorders Till 2025: Grand View Research,Inc.

(May 21, 2018)


"Grand View Research, Inc. - Market Research And Consulting."
According to report published by Grand View Research, The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025.Rising prevalence of neurodegenerative, orthopedic, oncology, tissue engineering, and nanotechnology to support regenerative therapies are expected to boost revenue growth.

The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to a new report by Grand View Research, Inc. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.

Developments in biotechnology have enabled gaining in-depth knowledge pertaining to cell division and differentiation as well as the metabolism mechanism of various cells. This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment.

Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Biologics, individually or in combination with cells or devices, are explored to support regenerate the biological functions of cells, tissues, or organs. A number of combinatorial therapies to support chemotherapy and other cancer treatments by prevention as well as treatment for cancer relapse are in development phases.

In addition, rising prevalence of complicated degenerative disorders such as age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the aging population resulted in high investments in R&D to develop therapeutic solutions.

Regenerative medicine grabs the attention of the healthcare industry owing to its promising applications along with significant advances in supportive fields including tissue engineering, stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D printing over scaffold with stem cells to restore structure as well as functional characteristics of biological cells, tissues, and organs.

Full research report on regenerative medicine market analysis: 

http://www.grandviewresearch.com/industry-analysis/regenerative-medicine-market

UK regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)

 

UK regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)

Further key findings from the report suggest:

  • The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner

  • Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption

  • Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment

  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.

  • Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/biotechnology

Global regenerative market revenue by therapeutic category, 2016 (%)

Global regenerative market revenue by therapeutic category, 2016 (%)

 

Grand View Research has segmented the global regenerative medicine market on the basis of product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Therapeutics & Devices

    • Primary Cell-bases therapeutics 

      • Dermatology

      • Musculoskeletal

      • Surgical

      • Dental

      • Others

    • Stem Cell & Progenitor Cell-based therapeutics

      • Autologous

      • Allogeneic

      • Others

    • Tools

    • Banks

    • Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 - 2025)

  • Dermatology

  • Musculoskeletal

  • Immunology & Inflammation

  • Oncology

  • Cardiovascular

  • Ophthalmology

  • Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

  • Middle East & Africa

    • South Africa

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research


Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: [email protected]
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/regenerative-medicine-market



Source: www.abnewswire.com


Page: 1


Related Keywords:Business,Manufacturing & Industry,Pharmaceuticals & Biotech,Science,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • ChenMed to Invest More Than $200 Million to Bring Affordable Concierge-Style Health Care to Philadelphia Seniors
  • $724 Million Viral Clearance Market by Application, End User, Method, Viral Inactivation - Global Forecasts to 2023
  • Global Viral Clearance Market 2018-2023 - Increasing Pharmaceutical Outsourcing & Emerging Markets Offer Opportunities
  • Global Automated Biochemistry Analyzers Market 2018-2022 - Increasing Use of Biochemical Tests for Pregnancy-Related Issues
  • The viral clearance market is projected to grow at a CAGR of 21.7%

    Cancer
  • Rose Medical Center's Cancer Program Re-Accredited by the Commission on Cancer
  • Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
  • GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  • SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S.
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines